You are here

Our science / Clinical Trials / Find a Trial / NCT00146159

Study Evaluating Mitoxantrone in Multiple Sclerosis

Back to Search Print Save as PDF Bookmark Trial

NCT00146159

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Berg, , D-82335 Germany
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Secondary Progressive Multiple Sclerosis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Secondary progressive MS in an active stage

- EDSS between 3 and 6

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Benign or primary progressive MS

- Patients with cardiac risk factors

- Patients who have already received mitoxantrone

NCT00146159
Pfizer
Terminated
Study Evaluating Mitoxantrone in Multiple Sclerosis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now